Almost all COVID-19 patients with mild and moderate disease severity demonstrate a robust adaptive immune response by B-cells (antibodies production against S-protein of SARS-CoV-2) and T-cells (against S-protein, nucleoprotein, and membrane protein antigens), which is consistent for several months after primary infection [30]. The gene discussed is PROS1; the disease is COVID-19.